Good morning, everyone, and welcome back from the long weekend. We hope the holiday was relaxing and invigorating. Now, of course, that familiar routine of meetings and deadlines and what-not has returned and, yes, we are coping the only way we know how - with a cup of stimulation. Feel free to join us. The busy season, as you know, is returning. To help you get started, here are a few of items of interest. Meanwhile, have a great day and stay in touch...
Valeant To Buy Medicis For $2.6 Billion (Bloomberg News)
Bayer Appeals India's Ruling On Bayer's Nexavar Generic (Pharma Times)
J&J Loses Bid To Toss $358M Risperdal Jury Award (Bloomberg News)
German Drugmaker Apologizes For Thalidomide Birth Defects (NBC News)
India To Pharma: Submit Six-Month Safety Reports On New Meds (Economic Times)
Dutch Begin 'No Cure, No Pay' Plan For New Drugs (Pharma Times)
Brazil Seizes Fake Merck Drugs (Securing Pharma)
Pharma Is To Blame For Sub-Standard APIs: WHO Official (In Pharma Technologist)
FDA Lifts Ban On Indian Pharma After Fixing Problems (Economic Times)
Spiriva Delayed Asthma Attacks In Study (Bloomberg News)
Pfizer Licenses Cancer Compound To VLST (Pharma Times)
New Pig Flu Strain Causes First Death (The Hill)
EDITOR'S NOTE: Please check this post for updates during the day
steaming coffee pic thx to dleggett on flickr